Patents matching “combination”

US 7452861

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

Theravance, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

US 7449182

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

US 7446124

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Nov 4, 2008 · Expires Oct 30, 2028

US 7445794

Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors

The Regents of the University of Colorado · Granted Nov 4, 2008 · Expires Oct 30, 2028

US 7435755

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System · Granted Oct 14, 2008 · Expires Oct 9, 2028

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

Rigel Pharmaceuticals, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

US 7361332

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Apr 22, 2008 · Expires Apr 17, 2028

US 7354581

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7331920

Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 19, 2008 · Expires Feb 14, 2028

US 7271161

Platinum complexes as antitumor agents in combination with biochemical modulation

The Board of Regents of the University of Texas System · Granted Sep 18, 2007 · Expires Sep 13, 2027

US 7186698

Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 6, 2007 · Expires Mar 1, 2027

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7087582

Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 6844320

Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor

The Board of Regents of the University of Texas System · Granted Jan 18, 2005 · Expires Jan 13, 2025

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same

The United States of America as represented by the Secretary of the Army · Granted Nov 30, 2004 · Expires Nov 25, 2024

US 6809075

Elastin peptide analogs and uses of same incombination with skin enhancing agents

Connective Tissue Imagineering, LLC · Granted Oct 26, 2004 · Expires Oct 21, 2024

US 6777389

Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides

Connective Tissue Imagineering, LLC · Granted Aug 17, 2004 · Expires Aug 12, 2024

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Jul 6, 2004 · Expires Jul 1, 2024

US 6630124

Combination therapy with VIP antagonist

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 7, 2003 · Expires Oct 2, 2023

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

The Board of Regents of the University of Texas System · Granted Sep 2, 2003 · Expires Aug 28, 2023

US 6582699

Combination vaccine for enhancing immunity against brucellosis

Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence in her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Jun 24, 2003 · Expires Jun 19, 2023

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Jun 17, 2003 · Expires Jun 12, 2023

US 6528284

Polynucleotides encoding proteins mediating switch recombination

The Regents of the University of California · Granted Mar 4, 2003 · Expires Feb 27, 2023

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Jan 7, 2003 · Expires Jan 2, 2023